Correlation Between Structure Therapeutics and Galecto
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Galecto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Galecto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Galecto, you can compare the effects of market volatilities on Structure Therapeutics and Galecto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Galecto. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Galecto.
Diversification Opportunities for Structure Therapeutics and Galecto
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Structure and Galecto is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Galecto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galecto and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Galecto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galecto has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Galecto go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Galecto
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Galecto. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 1.31 times less risky than Galecto. The stock trades about -0.28 of its potential returns per unit of risk. The Galecto is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 284.00 in Galecto on May 8, 2025 and sell it today you would earn a total of 56.00 from holding Galecto or generate 19.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Structure Therapeutics America vs. Galecto
Performance |
Timeline |
Structure Therapeutics |
Galecto |
Structure Therapeutics and Galecto Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Structure Therapeutics and Galecto
The main advantage of trading using opposite Structure Therapeutics and Galecto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Galecto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will offset losses from the drop in Galecto's long position.Structure Therapeutics vs. Terns Pharmaceuticals | Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. Acumen Pharmaceuticals | Structure Therapeutics vs. Amylyx Pharmaceuticals |
Galecto vs. Structure Therapeutics American | Galecto vs. IO Biotech | Galecto vs. Erasca Inc | Galecto vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |